Open AccessAn Overview on Contact Dermatitis: Simple Review
Author(s) -
Shahad Alzahrani,
Bandar Mohammed A. Abu Murad,
Rawan Lafi S. Alatawi,
Ghadah Eid M. Alatwi,
Wejdan Lafi S. Alatawi,
Hezam Shalan Alshahrani,
Anwar Abdullah M. Alghamdi,
Norah Abdo A. Hezam,
Rinad Rasheed M. Alrashidi,
Ahad S Alsharif,
Abeer Salamah M. Alsharif,
Alaa Nemer S. Alruwaili
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i40b32294
Subject(s) - itching , medicine , dermatology , contact dermatitis , allergic contact dermatitis , atopic dermatitis , irritant contact dermatitis , disease , allergy , immunology , pathology
Contact dermatitis (CD) is usually the result of cumulative exposure to sensitive irritants and accounts for 80% of all contact dermatitis cases. ICD can coexist with atopic dermatitis (AD) and allergic contact dermatitis (ACD). Patients with Alzheimer's disease and ACD may also have a lower infection threshold for ICD. Therefore, it must stand out from EA and CAD lesions. People with ICD have experienced uncontrolled tingling and burning sensations. Itching is typically manifested in patients with AD and ACD. Compared with AD and ACD, ICD lesions are usually well described. The prognosis of ICD is based on the exclusion method. Monitor patients to rule out type 1 and type 4 hypersensitivity reactions. A negative result indicates the prognosis of ICD. Management includes identifying and avoiding irritants through the normal use of emollients. Although ICD is older, it is not uncommon in some majors, and genetics and environment play a vital role in its development.